Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,823 across all filing types
Latest filing 2018-04-04 Director's Dealing
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Director's Dealing 2018
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details a transaction (Sale of shares) by a Member of the Board of Directors (Daniel John Bruno) of Genmab A/S on a specific date (2018-04-04). This structure perfectly matches the definition of a Director's Dealing report, which tracks personal share transactions by executives and directors.
2018-04-04 English
Director's Dealing 2018
Director's Dealing Classification · 99% confidence The document text is a template for the notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs) and persons closely associated with them. It details a transaction involving a Member of the Board of Directors (Daniel John Bruno) of Genmab A/S, specifically the 'Subscription of shares (exercise of warrants)' on a specific date (2018-04-03). This type of filing, which reports personal share transactions by company directors and executives, directly matches the definition for Director's Dealing (DIRS).
2018-04-03 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change Classification · 100% confidence The document is a formal company announcement from Genmab regarding an increase in share capital resulting from the exercise of employee warrants. It details the number of shares issued, the subscription prices, the total proceeds, and the updated total share capital. This falls directly under the category of share capital changes or issues.
2018-04-03 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change Classification · 100% confidence The document is a formal company announcement regarding a capital increase resulting from the exercise of employee warrants. It details the number of shares issued, the subscription prices, and the resulting change in the company's total share capital and voting rights. This falls directly under the definition of a share issue or capital change announcement.
2018-04-03 English
Director's Dealing 2018
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details transactions (Acquisition due to vesting of restricted stock units) made by members of the Board of Directors (Pernille Erenbjerg and Paolo Paoletti) concerning the company's shares. This type of insider transaction reporting directly corresponds to the definition of Director's Dealing.
2018-04-03 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change Classification · 100% confidence The document is a formal company announcement from Genmab regarding an increase in share capital resulting from the exercise of employee warrants. It details the number of shares issued, the subscription prices, the impact on total share capital, and the regulatory compliance with the Danish Capital Markets Act. This fits the definition of a 'Share Issue/Capital Change' (SHA) as it describes a specific event involving the issuance of new shares and a change in the company's capital structure.
2018-02-28 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.